422 related articles for article (PubMed ID: 34529193)
1. Paraproteinemia and neuropathy.
Koike H; Katsuno M
Neurol Sci; 2021 Nov; 42(11):4489-4501. PubMed ID: 34529193
[TBL] [Abstract][Full Text] [Related]
2. Update on the Diagnosis and Treatment of POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes) Syndrome: A Review.
Khouri J; Nakashima M; Wong S
JAMA Oncol; 2021 Sep; 7(9):1383-1391. PubMed ID: 34081097
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis and treatment of chronic acquired demyelinating polyneuropathies.
Latov N
Nat Rev Neurol; 2014 Aug; 10(8):435-46. PubMed ID: 24980070
[TBL] [Abstract][Full Text] [Related]
4. Two distinct mechanisms of neuropathy in immunoglobulin light chain (AL) amyloidosis.
Koike H; Mouri N; Fukami Y; Iijima M; Matsuo K; Yagi N; Saito A; Nakamura H; Takahashi K; Nakae Y; Okada Y; Tanaka F; Sobue G; Katsuno M
J Neurol Sci; 2021 Feb; 421():117305. PubMed ID: 33540321
[TBL] [Abstract][Full Text] [Related]
5. Different neurological and physiological profiles in POEMS syndrome and chronic inflammatory demyelinating polyneuropathy.
Nasu S; Misawa S; Sekiguchi Y; Shibuya K; Kanai K; Fujimaki Y; Ohmori S; Mitsuma S; Koga S; Kuwabara S
J Neurol Neurosurg Psychiatry; 2012 May; 83(5):476-9. PubMed ID: 22338030
[TBL] [Abstract][Full Text] [Related]
6. [New elements in the diagnosis and the treatment of primary AL amyloid polyneuropathy and neuropathy due to POEMS syndrome].
Adams D; Lozeron P; Theaudin M; Ribrag V; Bourhis JH; Lacroix C
Rev Neurol (Paris); 2011 Jan; 167(1):57-63. PubMed ID: 21190703
[TBL] [Abstract][Full Text] [Related]
7. Blink R1 latency utility in diagnosis and treatment assessment of polyradiculoneuropathy-organomegaly-endocrinopathy-monoclonal protein-skin changes and chronic inflammatory demyelinating polyradiculoneuropathy.
Wang W; Litchy WJ; Mauermann ML; Dyck PJB; Dispenzieri A; Mandrekar J; Dyck PJ; Klein CJ
Muscle Nerve; 2018 Jan; 57(1):E8-E13. PubMed ID: 28646568
[TBL] [Abstract][Full Text] [Related]
8. [Electrophysiologic aspects of Crow-Fukase (POEMS) syndrome--significance in early diagnosis and insights into the pathophysiology].
Misawa S
Brain Nerve; 2008 Jun; 60(6):595-601. PubMed ID: 18567354
[TBL] [Abstract][Full Text] [Related]
9. Chronic inflammatory demyelinating polyradiculoneuropathy-Diagnostic pitfalls and treatment approach.
Stino AM; Naddaf E; Dyck PJ; Dyck PJB
Muscle Nerve; 2021 Feb; 63(2):157-169. PubMed ID: 32914902
[TBL] [Abstract][Full Text] [Related]
10. Patterns of nerve conduction abnormalities in POEMS syndrome.
Sung JY; Kuwabara S; Ogawara K; Kanai K; Hattori T
Muscle Nerve; 2002 Aug; 26(2):189-93. PubMed ID: 12210381
[TBL] [Abstract][Full Text] [Related]
11. Uniform demyelination and more severe axonal loss distinguish POEMS syndrome from CIDP.
Mauermann ML; Sorenson EJ; Dispenzieri A; Mandrekar J; Suarez GA; Dyck PJ; Dyck PJ
J Neurol Neurosurg Psychiatry; 2012 May; 83(5):480-6. PubMed ID: 22396441
[TBL] [Abstract][Full Text] [Related]
12. [Polyneuropathy involving cranial nerves associated with monoclonal IgM antibodies with anti-MAG/SGPG/SGPLG/sulfatides activity].
Drouet A; Caudie C; Vallat JM; Ruel JH; Felten D; Guilloton L; Giraud P
Rev Neurol (Paris); 2006 Jun; 162(6-7):760-6. PubMed ID: 16840988
[TBL] [Abstract][Full Text] [Related]
13. Paraneoplastic neuropathies.
Graus F; Dalmau J
Curr Opin Neurol; 2013 Oct; 26(5):489-95. PubMed ID: 23892629
[TBL] [Abstract][Full Text] [Related]
14. [Cutting edge of diagnosis and treatment for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) based on the EAN/PNS guideline 2021].
Kuwabara S
Rinsho Shinkeigaku; 2024 May; 64(5):321-325. PubMed ID: 38644208
[TBL] [Abstract][Full Text] [Related]
15. Impact of 2021 European Academy of Neurology/Peripheral Nerve Society diagnostic criteria on diagnosis and therapy of chronic inflammatory demyelinating polyradiculoneuropathy variants.
De Lorenzo A; Liberatore G; Doneddu PE; Manganelli F; Cocito D; Briani C; Fazio R; Mazzeo A; Schenone A; Di Stefano V; Cosentino G; Marfia GA; Benedetti L; Carpo M; Filosto M; Antonini G; Clerici AM; Luigetti M; Matà S; Rosso T; Lucchetta M; Siciliano G; Lauria Pinter G; Cavaletti G; Inghilleri M; Cantisani T; Notturno F; Ricciardi D; Habetswallner F; Spina E; Peci E; Salvalaggio A; Falzone Y; Strano C; Gentile L; Vegezzi E; Mataluni G; Cotti Piccinelli S; Leonardi L; Romano A; Nobile-Orazio E;
Eur J Neurol; 2024 Apr; 31(4):e16190. PubMed ID: 38165011
[TBL] [Abstract][Full Text] [Related]
16. [Advances and perspectives in treatment for refractory neuropathies with special reference to immune-mediated neuropathies and Crow-Fukase syndrome].
Kuwabara S
Rinsho Shinkeigaku; 2010 Apr; 50(4):219-24. PubMed ID: 20411803
[TBL] [Abstract][Full Text] [Related]
17. Electrophysiological features of POEMS syndrome and chronic inflammatory demyelinating polyneuropathy.
Guo X; Qin X; Zhang Y; Huang C; Yu G
J Clin Neurosci; 2014 Apr; 21(4):587-90. PubMed ID: 24268501
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal gammopathy and neuropathy.
Lozeron P; Adams D
Curr Opin Neurol; 2007 Oct; 20(5):536-41. PubMed ID: 17885441
[TBL] [Abstract][Full Text] [Related]
19. Thrombocytosis distinguishes POEMS syndrome from chronic inflammatory demyelinating polyneuropathy.
Naddaf E; Dispenzieri A; Mandrekar J; Mauermann ML
Muscle Nerve; 2015 Oct; 52(4):658-9. PubMed ID: 26179010
[TBL] [Abstract][Full Text] [Related]
20. Non-anti-MAG DADS neuropathy as a variant of CIDP: clinical, electrophysiological, laboratory features and response to treatment in 10 cases.
Larue S; Bombelli F; Viala K; Neil J; Maisonobe T; Bouche P; Musset L; Fournier E; Léger JM
Eur J Neurol; 2011 Jun; 18(6):899-905. PubMed ID: 21199182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
